163 related articles for article (PubMed ID: 36573915)
1. Correlation of response to subthalamic deep brain stimulation in Parkinson's disease patients with striatal dopamine transporter density on 99mtc-TRODAT-1 SPECT.
Ghaedian T; Razmkon A; Kalhor L; Ostovan VR; Yousefi O; Rezaei R; Hossein-Tehrani MR; Rakhsha A
Neurol Res; 2023 Jun; 45(6):505-509. PubMed ID: 36573915
[TBL] [Abstract][Full Text] [Related]
2. Use of
Dongfang C; Xianzhi M; Cen L; Zhongke H
Hell J Nucl Med; 2022; 25(3):247-252. PubMed ID: 36507880
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
J Neurosurg; 2021 Feb; 135(5):1429-1435. PubMed ID: 33607613
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
Nakajima A; Shimo Y; Sekimoto S; Kamagata K; Jo T; Oyama G; Umemura A; Hattori N
J Neurol Sci; 2018 Feb; 385():134-139. PubMed ID: 29406893
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
6. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson's disease.
Lee SH; Kim M; Lee J; Kim JW; Kim MS; Jo S; Jeon SR; Chung SJ
Sci Rep; 2022 Oct; 12(1):16870. PubMed ID: 36207312
[TBL] [Abstract][Full Text] [Related]
8. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
11. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
13. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
[TBL] [Abstract][Full Text] [Related]
14. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
16. Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson's disease.
Fayed I; Cobourn KD; Pivazyan G; Torres-Yaghi YA; Pagan FL; Lo SE; Mandir AS; Kalhorn CG
J Clin Neurosci; 2021 Mar; 85():92-100. PubMed ID: 33581797
[TBL] [Abstract][Full Text] [Related]
17. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
[TBL] [Abstract][Full Text] [Related]
18. Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.
Hesse S; Strecker K; Winkler D; Luthardt J; Scherfler C; Reupert A; Oehlwein C; Barthel H; Schneider JP; Wegner F; Meyer P; Meixensberger J; Sabri O; Schwarz J
J Neurol; 2008 Jul; 255(7):1059-66. PubMed ID: 18446306
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
